in the zoladex versus orchiectomy trial , there was no significant difference between the treatment groups with regard to subjective and objective responses ( british prostate group criteria ) , endocrine responses , clinical effects and side effects , time to treatment failure and death , or survival after similar median follow-up periods .
C0029189
orchiectomy
C0014136
endocrine